Evome Medical Technologies Inc.
LNDZF
$0.0041
-$0.0027-39.71%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.31M | -14.24M | -13.40M | -11.45M | -3.54M |
| Total Depreciation and Amortization | 1.79M | 3.15M | 3.42M | 3.34M | 3.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.03M | 12.26M | 8.20M | 8.04M | 1.33M |
| Change in Net Operating Assets | 3.45M | 1.39M | 1.25M | -619.10K | -1.21M |
| Cash from Operations | 3.95M | 2.56M | -535.30K | -690.40K | -382.50K |
| Capital Expenditure | -26.70K | -79.10K | -110.70K | -151.10K | -594.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -979.30K | -979.30K | -1.67M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -40.20K |
| Cash from Investing | -26.70K | -79.10K | -1.09M | -1.13M | -2.31M |
| Total Debt Issued | -197.80K | -2.07M | -1.97M | 949.20K | 649.60K |
| Total Debt Repaid | -5.88M | -2.32M | -35.40K | -158.50K | -920.90K |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 33.90K | 33.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -4.22M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 1.24M |
| Cash from Financing | -4.45M | -3.22M | -1.48M | 615.30K | -2.36M |
| Foreign Exchange rate Adjustments | 784.20K | 481.30K | 528.60K | 445.80K | 177.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 256.20K | -250.20K | -2.58M | -759.90K | -4.88M |
